Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
301
datasets available to search
ShareScore release 0.9.0
Dataset results
301 results for “sitagliptin”
Metabolic Responses of Dapagliflozin vs Sitagliptin in T2DM Patients Inadequately Controlled With Insulin Therapy
ClinicalTrials.gov study NCT03959501. IPD Sharing: NO. Countries: 1. Publications: 0.
Treatment With Sitagliptin for Reactive Hypoglycemia Secondary to Dysinsulinism
ClinicalTrials.gov study NCT00847080. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase III Trial to Evaluate the Efficacy and Safety of LC15-0444 Compared With Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT01602003. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sitagliptin Treatment in Patients With Type 2 DM After Kidney Transplant
ClinicalTrials.gov study NCT00466518. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Post Marketing Safety Study of Sitagliptin Phosphate/Metformin Hydrochloride (JANUMET®) (MK-0431A-235)
ClinicalTrials.gov study NCT01357148. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Doses of JNJ-38431055, Sitagliptin, and Co-administration of JNJ-38431055 and Sitagliptin
ClinicalTrials.gov study NCT01054118. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Characterize the Effect on the Pharmacokinetics of ASP1941 and Sitagliptin When Given Together to Healthy Subjects
ClinicalTrials.gov study NCT01104532. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of the Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic
ClinicalTrials.gov study NCT01678820. IPD Sharing: YES. Countries: 0. Publications: 0.
Effect of Sitagliptin in Impaired Glucose Tolerance
ClinicalTrials.gov study NCT00961363. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of CWP-0403 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin Alone
ClinicalTrials.gov study NCT01529541. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effects of Lansoprazole on Sitagliptin Glucose-lowering Ability in Healthy Males: a Randomised Crossover Study
ClinicalTrials.gov study NCT01820104. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Metformin and Sitagliptin in Women With Previous Gestational Diabetes
ClinicalTrials.gov study NCT01336322. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Drug Interaction Study Between Dorzagliatin and Sitagliptin
ClinicalTrials.gov study NCT03790839. IPD Sharing: NO. Countries: 1. Publications: 0.
To Compare the Safety and Efficacy of Dapagliflozin Plus Metformin Versus Sitagliptin Plus Metformin for Treatment of Diabetes in Patients With Compensated and Stable Decompensated Cirrhosis
ClinicalTrials.gov study NCT06147518. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Pharmacokinetic Study of SID1903 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers
ClinicalTrials.gov study NCT05236998. IPD Sharing: NO. Countries: 1. Publications: 0.
Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 100 mg /1000 mg (FDC) in Healthy Adult Male and Female Subjects Under Fed Conditions.
ClinicalTrials.gov study NCT06124573. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation of the DPP-4 Inhibitor Sitagliptin in the Treatment of Non-Alcoholic Fatty Liver Disease Using MRI
ClinicalTrials.gov study NCT02263677. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of the Effects of Co-Administration of Sitagliptin (MK-0431) and Metformin on Incretin Hormone Concentrations (MK-0431-110)
ClinicalTrials.gov study NCT00830076. IPD Sharing: YES. Countries: 0. Publications: 0.
The Effect of Sitagliptin, Pioglitazone and Dapagliflozine on Myocardial Infarction in Diabetic Rats
ClinicalTrials.gov study NCT07083232. IPD Sharing: YES. Countries: 1. Publications: 0.
Treatment With Sitagliptin in Non-obese Japanese Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT01642108. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.